Sectors
BEAM
Beam Therapeutics Inc.
26.77
1 x 26.81
1 x 26.85
bid
ask
-
0.52
1.90%
11:13 AM
timesize
| Ytd | -3.42% | |
| 1y | 24.29% |
26.60
day range
27.17
15.60
52 week range
38.26
| Open | 26.92 | Prev Close | 27.29 | Low | 26.60 | High | 27.17 | Mkt Cap | 2.81B |
| Vol | 248.68K | Avg Vol | 2.34M | EPS | -3.11 | P/E | -8.77 | Forward P/E | -6.91 |
| Beta | 2.18 | Short Ratio | 9.65 | Inst. Own | 106.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 31.35 | 200-d Avg | 28.11 | 1yr Est | 51.36 |
| Income Statement | |||
| Total Revenue | 31.74M | ||
| Revenues (USD) | 31.74M | ||
| Gross Profit | 31.74M | ||
| Operating Expenses | 138.95M | ||
| Research and Development Expense | 104.52M | ||
| Selling, General and Administrative Expense | 34.43M | ||
| Operating Income | -107.21M | ||
| Net Income | -94.32M | ||
| Net Income Common Stock | -94.32M | ||
| Net Income Common Stock (USD) | -94.32M | ||
| Consolidated Income | -94.32M | ||
| Earnings per Basic Share | -0.91 | ||
| Earnings per Basic Share (USD) | -0.91 | ||
| Earnings per Diluted Share | -0.91 | ||
| Earning Before Interest & Taxes (EBIT) | -94.32M | ||
| Earning Before Interest & Taxes (USD) | -94.32M | ||
| Weighted Average Shares | 103.26M | ||
| Weighted Average Shares Diluted | 103.26M | ||
| Balance Sheet | |||
| Cash and Equivalents | 294.98M | ||
| Cash and Equivalents (USD) | 294.98M | ||
| Investments | 923.36M | ||
| Investments Current | 923.36M | ||
| Current Assets | 1.27B | ||
| Property, Plant & Equipment Net | 199.40M | ||
| Total Assets | 1.48B | ||
| Debt Current | 14.78M | ||
| Total Debt | 250.82M | ||
| Current Liabilities | 74.57M | ||
| Debt Non-Current | 236.04M | ||
| Total Liabilities | 316.36M | ||
| Accumulated Retained Earnings (Deficit) | -1.74B | ||
| Accumulated Other Comprehensive Income | -1.07M | ||
| Shareholders Equity | 1.16B | ||
| Shareholders Equity (USD) | 1.16B | ||
| Assets Non-Current | 213.85M | ||
| Total Debt (USD) | 250.82M | ||
| Deferred Revenue | 304.00K | ||
| Liabilities Non-Current | 241.80M | ||
| Trade and Non-Trade Payables | 12.29M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.61M | ||
| Net Cash Flow from Financing | 96.61M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -6.64M | ||
| Capital Expenditure | -2.23M | ||
| Issuance (Purchase) of Equity Shares | 3.54M | ||
| Issuance (Repayment) of Debt Securities | 93.07M | ||
| Net Cash Flow from Investing | 25.27M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 27.50M | ||
| Net Cash Flow from Operations | -128.51M | ||
| Share Based Compensation | 19.04M | ||